πŸ‡ΊπŸ‡Έ FDA
Patent

US 10406177

Modified cells and methods of therapy

granted A61KA61K2239/38A61K40/11

Quick answer

US patent 10406177 (Modified cells and methods of therapy) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K2239/38, A61K40/11, A61K40/22, A61K40/32